BioIntelliSense, Inc. — Form D/A

BioIntelliSense, Inc. of GOLDEN, CO, a company, filed a Form D amendment with the SEC on 2026-06-04. The offering totals $58.4M, of which $58.3M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Conlan MaRelated PersonGolden, CO
James MaultRelated PersonGolden, CO
David WangRelated PersonLos Angeles, CA
Xinyaun YuRelated PersonGolden, CO
Xinyaun YuDirectorGolden, CO
Conlan MaDirectorGolden, CO
David WangDirectorLos Angeles, CA
David WangExecutive OfficerLos Angeles, CA
Dawn OwensDirectorMINNEAPOLIS, MN
James MaultDirectorGolden, CO
James MaultExecutive OfficerGolden, CO
STEVE HESSDirectorLEWES, DE
David R WangExecutive OfficerGolden, CO
Alan R MeekerDirectorGolden, CO
James R MaultDirectorGolden, CO
James R MaultExecutive OfficerGolden, CO
John R DriscollDirectorGolden, CO
Lawrence R LeisureDirectorGolden, CO
Steve R HessDirectorGolden, CO
Larry LeisureDirectorPleasanton, CA
Ronald ChwangDirectorSeattle, WA
Alan MeekerDirectorGolden, CO

Other filings by this issuer (4)

FiledFormOfferingSold
2025-12-19D$58.4M$58.1M
2022-09-15D$45.0M$45.0M
2020-09-10D$12.0M$12.0M
2020-09-10D$25.0M$25.0M

More